quinazolines has been researched along with aniline in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| App, H; Chen, I; Chen, J; Gazit, A; Hirth, P; Levitzki, A; McMahon, G | 1 |
| Ballard, P; Barlaam, BC; Bradbury, RH; Dishington, A; Hennequin, LF; Hickinson, DM; Hollingsworth, IM; Kettle, JG; Klinowska, T; Ogilvie, DJ; Pearson, SE; Scott, JS; Suleman, A; Whittaker, R; Williams, EJ; Wood, R; Wright, L | 1 |
| Chandrasekara Reddy, G; Chandregowda, V; Kush, AK | 1 |
| Azas, N; Dumètre, A; Gellis, A; Hutter, S; Kabri, Y; Laget, M; Vanelle, P; Verhaeghe, P | 1 |
| Fujii, N; Ohno, H; Ohta, Y; Oishi, S; Tokimizu, Y | 1 |
| Ge, ZM; Li, QY; Li, RD; Li, RT; Zhang, X | 1 |
| Brdar, I; Deng, X; Faessler, R; Mani, NS; Roessler, A; Sales, ZS; Wu, J | 1 |
| Hauf, S; Koch, A; Rauh, D; Richters, A; Rode, HB | 1 |
| Feng, C; Wang, Z; Yan, Y; Zha, Z; Zhang, Y | 1 |
| Kumar, M; Kumar, N; Kumar, V; Sharma, S | 1 |
| Cheng, W; Hu, Y; Peng, P; Qiu, N; Sheng, R; Yuan, Y | 1 |
| Cimarelli, C; Di Nicola, M; Diomedi, S; Giovannini, R; Hamprecht, D; Marcantoni, E; Properzi, R; Sorana, F | 1 |
| Liu, K; Ma, X; Shu, X; Sun, Y; Wang, C; Wang, Q; Wu, B; Zhen, Y; Zhou, Y; Zhu, X | 1 |
| An, L; Gao, CY; Li, CL; Liu, Y; Meng, L; Wu, XQ; Xu, L; Zhang, L; Zhang, WQ; Zheng, YG | 1 |
| Abdel-Rahman, HM; Amin, NH; Elsaadi, MT; Zaki, SS | 1 |
15 other study(ies) available for quinazolines and aniline
| Article | Year |
|---|---|
Tyrphostins IV--highly potent inhibitors of EGF receptor kinase. Structure-activity relationship study of 4-anilidoquinazolines.
Topics: Aniline Compounds; ErbB Receptors; Phosphorylation; Protein Kinase C; Quinazolines; Staurosporine; Structure-Activity Relationship | 1996 |
Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
Topics: Administration, Oral; Aniline Compounds; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Dogs; Drug Synergism; Mice; Molecular Structure; Neoplasms; Quinazolines; Rats; Receptor, ErbB-2; Triazoles; Xenograft Model Antitumor Assays | 2007 |
Synthesis and in vitro antitumor activities of novel 4-anilinoquinazoline derivatives.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; ErbB Receptors; Gefitinib; Humans; Models, Molecular; Neoplasms; Phosphotransferases; Protein Structure, Tertiary; Quinazolines | 2009 |
Original quinazoline derivatives displaying antiplasmodial properties.
Topics: Aniline Compounds; Animals; Antiprotozoal Agents; Cell Line; Drug Design; Humans; Inhibitory Concentration 50; Leishmania donovani; Phosphotransferases; Plasmodium falciparum; Quinazolines; Toxoplasma | 2010 |
Direct synthesis of quinazolines through copper-catalyzed reaction of aniline-derived benzamidines.
Topics: Aniline Compounds; Benzamidines; Catalysis; Combinatorial Chemistry Techniques; Copper; Cyclization; Molecular Structure; Quinazolines | 2010 |
Novel EGFR inhibitors prepared by combination of dithiocarbamic acid esters and 4-anilinoquinazolines.
Topics: Aniline Compounds; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Esters; Humans; Molecular Structure; Quinazolines; Structure-Activity Relationship; Thiocarbamates | 2011 |
Direct, metal-free amination of heterocyclic amides/ureas with NH-heterocycles and N-substituted anilines in POCl3.
Topics: Amides; Amination; Aniline Compounds; Anticholesteremic Agents; Azabicyclo Compounds; Benzamides; Catalysis; Chemistry, Pharmaceutical; Erlotinib Hydrochloride; Eszopiclone; Fluorobenzenes; Heterocyclic Compounds; Humans; Hydrogen-Ion Concentration; Hypnotics and Sedatives; Hypoglycemic Agents; Imatinib Mesylate; Molecular Structure; Phosphorus Compounds; Piperazines; Prescription Drugs; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Rosiglitazone; Rosuvastatin Calcium; Sulfonamides; Thiazolidinediones; Urea | 2011 |
A chemical genetic approach for covalent inhibition of analogue-sensitive aurora kinase.
Topics: Aniline Compounds; Aurora Kinases; Drug Design; Genetic Engineering; Molecular Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Quinazolines; Schizosaccharomyces | 2012 |
Selective iodine-catalyzed intermolecular oxidative amination of C(sp3)-H bonds with ortho-carbonyl-substituted anilines to give quinazolines.
Topics: Amination; Aniline Compounds; Catalysis; Hydrogen Bonding; Iodine; Molecular Structure; Oxidation-Reduction; Quinazolines | 2012 |
Metal-free transfer hydrogenation of nitroarenes in water with vasicine: revelation of organocatalytic facet of an abundant alkaloid.
Topics: Alkaloids; Aniline Compounds; Catalysis; Chemical Phenomena; Hydrogenation; Justicia; Metals; Nitro Compounds; Plant Leaves; Quinazolines; Water | 2014 |
Identification of novel 4-anilinoquinazoline derivatives as potent EGFR inhibitors both under normoxia and hypoxia.
Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Binding Sites; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; HT29 Cells; Humans; Molecular Docking Simulation; NADP; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Quinazolines; Structure-Activity Relationship | 2014 |
An efficient one-pot two catalyst system in the construction of 2-substituted benzimidazoles: synthesis of benzimidazo[1,2-c]quinazolines.
Topics: Aniline Compounds; Benzimidazoles; Catalysis; Chemistry Techniques, Analytical; Molecular Structure; Quinazolines; Schiff Bases | 2015 |
Novel Quinazoline Derivatives Bearing Various 4-Aniline Moieties as Potent EGFR Inhibitors with Enhanced Activity Against NSCLC Cell Lines.
Topics: Aniline Compounds; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Humans; Lung Neoplasms; Magnetic Resonance Spectroscopy; Quinazolines; Spectrometry, Mass, Electrospray Ionization | 2016 |
Design, synthesis and biological evaluation of 4-aniline quinazoline derivatives conjugated with hydrogen sulfide (H
Topics: Aniline Compounds; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Hydrogen Sulfide; Molecular Structure; Mutation; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship | 2020 |
Design, synthesis and molecular modeling studies of 2-styrylquinazoline derivatives as EGFR inhibitors and apoptosis inducers.
Topics: A549 Cells; Aniline Compounds; Antineoplastic Agents; Apoptosis; Benzenesulfonamides; Caspase 3; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Quinazolines; Sulfonamides | 2020 |